The majority of patients suffering from mild or moderate Crohn's disease can be treated as outpatients. In some cases, however, hospitalization is unavoidable.
Some laboratory values can help in the choice of therapy. For example, the CRP value provides information about the course of the disease. This value can also be used to assess the risk of relapse. If there is an inflammatory process in the body, the amount of C-reactive protein (CRP) in the blood increases. In addition, the number and condition of the red blood cells (erythrocytes) are determined in order to detect any anaemia.
Therapy for an acute flare is divided into three stages, depending on the severity of the flare:
Low activity:
The first choice is local therapy with the corticosteroid (cortisone) budesonide (per day as a single dose or three single doses spread throughout the day).
If the affected person has no symptoms outside the digestive tract (extraintestinal manifestation), sometimes nutritional therapy or symptomatic therapy (such as agents for pain, cramps, and the diarrhea) may be sufficient.
Moderate activity:
In this case, budesonide or systemic (acting throughout the body) cortisone preparations are usually used. Sometimes nutritional therapy can also help. Antibiotics are also given if it may be a bacterial infection.
High activity: In this case, cortisone preparations are usually given, and possibly other medications that help suppress the immune system (such as azathioprine). If these drugs do not achieve the desired effect and surgery is not possible, there is also the possibility of administering antibodies against inflammatory factors (TNF antibodies).
Therapy in the resting phase (remission maintenance):
In a large proportion of patients, there is an alternation between episodes of disease and a symptom-free period (remission phase). Treatment during this symptom-free period is not absolutely necessary. Individual factors, such as the course of the disease, determine whether, how long and which drugs are used in such remission-maintaining therapy.
Medications:
Since the reasons for the disease are often unknown, only the inflammation can be fought and the symptoms relieved. With the help of medication, a possible relapse can also be prevented over a certain period of time.
The following medications are used for Crohn's disease:
- 5-ASA: Mesalazine or sulfasalazine develop their effect specifically either in the small intestine or only in the large intestine. These drugs are less effective in Crohn's disease than in ulcerative colitis, which is why they are only given in cases of mild disease progression.
- Cortisone preparations: The endogenous hormone cortisone has an anti-inflammatory effect and curbs the activity of the immune system. Chemically synthesized cortisone preparations play an important role during an acute Crohn's disease attack. If the symptoms are only mild or moderate, or if the focus of inflammation is in the lower part of the colon, these preparations act directly on the spot (as suppositories or enema preparations). This results in fewer side effects. For more severe symptoms, tablets whose active ingredient is distributed throughout the body (systemic) are preferred.
- Antibiotics: Antibiotics, such as metronidazole or ciprofloxacin, are mainly used when there is a bacterial infection, in addition to intestinal inflammation, or when it threatens to develop. The therapy is mainly used for fistulas. Fistulas are newly formed connections between the intestine and the surrounding tissue or organs. The danger of these fistulas is that they can cause infections by intestinal bacteria outside the intestine.
- Drugs that suppress the immune system (immunosuppressants): These are used in severe cases of Crohn's disease. If cortisone preparations do not have the desired effect, if the side effects are too severe or if they cannot be taken for some other reason, immunosuppressants are used. Very often this involves the active substance azathioprine.
- TNF antibodies: In very severe cases, anti-inflammatory drugs with the active ingredients Infliximab or Adalimumab are used (TNF antibodies). The active principle of these substances is that they bind messenger substances (cytokines) between the inflammatory cells and thus prevent the spread of the inflammatory reaction.
Surgical intervention:
Around 70 percent of those affected are not spared surgery within the first fifteen years of illness. This can also be the case despite drug therapy. Often, repeated operations may also be possible. During an operation, the following interventions take place:
- The surgeon expands narrowed areas in the intestine with the help of a balloon.
- Fistulas are closed and abscesses are cut open.
- Sections of the intestine that are already heavily affected by inflammation are removed. This procedure is only performed if there are already serious complications, such as intestinal perforation, peritonitis or intestinal obstruction.
Proper nutrition:
Proper nutrition plays an important role in Crohn's disease patients, although there are no general guidelines for it. It is best to seek advice from the doctor on how to avoid deficiencies in vitamins, protein, iron or nutrients. During an acute episode, a high-fiber diet (astronaut food) often provides relief. Patients who suffer from particularly severe episodes receive nutrition through a drip to bring relief to the irritated bowel.
What you can do yourself:
If you already have Crohn's disease, you should watch for any sign that might indicate a worsening. Blood in the stool, new or different pain, and unexplained fever may be such signs.
During an acute Crohn's disease flare, it is essential to give the body adequate rest. Between relapses, normal work can be done.
There are no restrictions on diet. However, care should be taken that no deficiency symptoms occur due to the attacked intestine. This can be achieved with a healthy diet.
If there are intolerances to certain foods, these should be avoided. About 30 percent of patients cannot tolerate lactose (lactose intolerance). If this is the case, milk and milk products should be eliminated from the diet. Other Crohn's disease patients unfortunately suffer from fructose intolerance and must therefore avoid fructose.